Breast-cancer stromal cells with TP53 mutations [5]

New England Journal of Medicine

Volumn 358, Issue 15, 2008, Pages 1635-

  Zander, Cecilia Soussi ^a   Soussi, Thierry ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; PARAFFIN;

AMINO ACID SUBSTITUTION; BREAST CANCER; FAMILIAL CANCER; GENE MUTATION; HUMAN; LETTER; MUTATIONAL ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; BREAST TUMOR; EPITHELIUM; GENETICS; MUTATION; NOTE; STROMA CELL; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; EPITHELIUM; GENES, P53; HUMANS; MUTATION; PARAFFIN EMBEDDING; STROMAL CELLS;

EID: 42049093400     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Williams C, Norberg T, Ahmadian A, et al. Assessment of sequence-based p53 gene analysis in human breast cancer: messenger RNA in comparison with genomic DNA targets. Clin Chem 1998;44:455-62.
2. Børresen-Dale AL. TP53 and breast cancer. Hum Mutat 2003;21:292-300.
3. Soussi T, Ishioka C, Claustres M, Béroud C. Locus-specific mutation databases: pitfalls and good practice based on the p53 experience. Nat Rev Cancer 2006;6:83-90.
4. Soussi T, Asselain B, Hamroun D, et al. Meta-analysis of the p53 mutation database for mutant p53 biological activity reveals a methodologic bias in mutation detection. Clin Cancer Res 2006;12:62-9.